Antibodies under a microscope

DHD10804

Research Grade Blinatumomab

Description

Bispecific, CD19, AMG103, BITE MT-103, MEDI-538, MT103, bscCD19xCD3, CAS: 853426-35-4

Targets

CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain

Isotype/Mimetic

(scFv-kappa-heavy)-(scFv-heavy-kappa)

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression